Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
It was later discovered that one of the donors was HIV positive, leading to her infection..HIV, AIDS, Cancer patient, RCC, Kerala High Court ...
A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
Prof. Francisca Mutapi, a global health expert suggests 4 ways to end the dependence HEALTH | FRANCISCA MUTAPI | There’s been a global trend in the reduction of aid to Africa since 2018. Donors are ...
The results, published in Current Oncology in December, showed 88 per cent of participants chose the self-sample option and ...
A bill to ensure NH’s Medicaid program doesn’t pay for circumcisions unless medically necessary was approved by the House by ...